Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Additionally, in September, we announced that the FDA granted Fast Track designation for KT-333 for the treatment of relapsed/refractory cutaneous T-cell lymphoma and relapsed/refractory peripheral T-cell cell lymphoma.
In 2012, Shin founded Fast Track Asia, and by 2020, Shin was working on the project that would become PortOne Global.
The FDA's Fast Track designation is intended to facilitate and expedite the development and review of new drugs which address high unmet medical needs in the treatment of serious or life-threatening conditions.